seed
Stage
1
Investors
About
PharmatrophiX is a clinical-stage biopharmaceutical company developing small-molecule drug therapies targeting neurodegenerative diseases by modulating neurotrophin receptors to prevent neurodegeneration and promote synaptic resilience.
Explore PharmatrophiX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.